Private Equity-Backed Cardiology Group Teams with HybridChart for Advanced Rounding Tech

By

Disclaimer: Images on MEDWIRE.AI are AI-generated for illustrative purposes and are not affiliated with, endorsed by, or representative of any specific company, product, or technology.

Cardiovascular Associates of America (CVAUSA), a Florida-based private equity-backed cardiology management group, has partnered with HybridChart to deploy its advanced mobile rounding technology across all CVAUSA practices.

Founded in 2008 by cardiologist Gregory Sanders, MD, HybridChart offers a standardized platform that provides cardiologists quick, seamless access to comprehensive patient data. This technology supports efficient workflows and improves shared decision-making—key components as value-based care continues to shape healthcare delivery.

Highlights:

  • HybridChart is now the preferred rounding technology for all CVAUSA cardiologists.
  • The platform enables uniform data capture and enhanced visibility into practice performance.
  • CVAUSA CEO Tim Attebery emphasized the partnership’s role in optimizing operations and advancing value-based care strategies.
  • HybridChart CEO Gregory Sanders highlighted the collaboration as a step toward superior patient care and improved clinical outcomes.

This alliance reflects a growing trend of leveraging digital tools to boost efficiency and quality in cardiology practices.

Follow MEDWIRE.AI for updates on cardiology care delivery and health tech partnerships.